恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01276 恒瑞医药

交易中 08-14 14:02:00

78.100

-0.700

-0.89%

最高80.000	最低77.600	成交量444.60万
今开79.900	昨收78.800	日振幅3.05%
总市值5,183亿	流通市值201.50亿	总股本66.37亿
成交额3.50亿	换手率1.72%	流通股本2.58亿
市净率10.08	ROE15.22%	每股收益1.09
52周最高87.800	52周最低52.500	市盈率71.38
股息0.22	股息收益率0.00	ROA8.99%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":78.1,"timestamp":1755151317143,"preClose":78.8,"halted":0,"volume":4445986,"delay":0,"floatShares":258000000,"shares":6637000000,"eps":1.0940806203497315,"marketStatus":"交易中","change":-0.7,"latestTime":"08-14 14:02:00","open":79.9,"high":80,"low":77.6,"amount":350354464,"amplitude":0.030457,"askPrice":78.15,"askSize":8000,"bidPrice":78.1,"bidSize":8200,"shortable":3,"etf":0,"ttmEps":1.194104752903965,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1755159000000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":78.8,"dividendRate":0.002802,"openAndCloseTimeList":[[1755135000000,1755144000000],[1755147600000,1755158400000]],"volumeRatio":1.750971,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":62.88,"timestamp":1755151317000,"preClose":62.61,"halted":0,"volume":47326900,"delay":0,"premium":"+13.52"}},"requestUrl":"/m/hq/s/01276","defaultTab":"news","newsList":[{"id":"2559560381","title":"恒瑞医药(01276)：注射用SHR-A2102、阿得贝利单抗注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2559560381","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559560381?lang=zh_cn&edition=full","pubTime":"2025-08-13 17:15","pubTimestamp":1755076510,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药 发布公告，近日，公司子公司苏州盛迪亚生物医药有限公司、上海恒瑞医药有限公司、上海盛迪医药有限公司收到国家药品监督管理局核准签发关于注射用 SHR-A2102、阿得贝利单抗注射液的《药物临床试验批准通知书》，将于近期开展临床试验。注射用 SHR-A2102 为公司自主研发且具有知识产权的靶向 Nectin-4 的抗体药物偶联物，其有效载荷是拓扑异构酶Ⅰ抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2543165471.USD","LU1997245177.USD","LU2488822045.USD","LU2328871848.SGD","BK0183","LU1255011170.USD","600276","BK0028","LU2148510915.USD","LU2495084118.USD","LU1969619763.USD","BK0188","LU1655091616.SGD","LU1997244956.HKD","LU0405327494.USD","LU1064131003.USD","01276","BK0060","LU1997245094.SGD","LU2580892789.USD","LU0405327148.USD","BK1191","LU1064130708.USD","BK0239","BK0196","BK0012","LU2580892862.HKD","LU1328615791.USD"],"gpt_icon":0},{"id":"2559608323","title":"恒瑞医药：子公司SHR-A2102及阿得贝利单抗注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2559608323","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559608323?lang=zh_cn&edition=full","pubTime":"2025-08-13 16:40","pubTimestamp":1755074443,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2328871848.SGD","BK1515","LU1969619763.USD","ADC","LU2580892862.HKD","BK1574","LU2488822045.USD","01276","BK1191","LU1064130708.USD","LU1655091616.SGD","BK0012","BK0239","LU1169589451.USD","LU2495084118.USD","BK1161","LU1997245177.USD","LU1169590202.USD","LU2580892789.USD","BK0060","BK0183","BK4231","399441","LU2148510915.USD","LU2543165471.USD","LU0405327494.USD","LU0405327148.USD","BK0188","PD","09939","159938","BK0196","LU1255011170.USD","600276","LU1997244956.HKD","LU1328615791.USD","BK0028","BK4023","BK4080","161726","LU1997245094.SGD","LU1064131003.USD"],"gpt_icon":0},{"id":"2559934670","title":"智通AH统计|8月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2559934670","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559934670?lang=zh_cn&edition=full","pubTime":"2025-08-13 16:15","pubTimestamp":1755072906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止8月13日收盘，东北电气、弘业期货、安德利果汁分列AH溢价率前三位，溢价率分别为800.00%、224.47%、219.79%；宁德时代、恒瑞医药、招商银行分列AH溢价率末三位，溢价率分别为-22.45%、-4.84%、4.09%。其中安德利果汁、北京北辰实业股份、金力永磁的偏离值位居前三，分别为30.94%、16.61%、15.22%；另外，比亚迪股份、东北电气、龙蟠科技的偏离值位居后三，分别为-158.79%、-64.08%、-41.16%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00588","01033","01456","01057","06178","03968","06127","02338","00916","06680","LU0211977185.USD","03678","02628","02238","01812","01618","06066","02899","LU0417516902.SGD","LU0516423091.SGD","LU0918141705.HKD","LU1831875114.USD","HYDD.SI","02465","81211","01288","159982","01276","LU0327786744.USD","002594","03750","00895","00042","02359","02865","00187","IE00BGHQDM52.EUR","00300","399300","03143","06869","BYDDY","LU0315178854.USD","01349","00914","02218"],"gpt_icon":1},{"id":"2559052675","title":"港股异动 | 恒瑞医药(01276.HK)涨超3% 海曲泊帕乙醇胺片药品上市许可申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2559052675","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559052675?lang=zh_cn&edition=full","pubTime":"2025-08-13 11:04","pubTimestamp":1755054260,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0196","BK0028","BK0188","LU1997244956.HKD","LU2495084118.USD","LU1255011170.USD","LU1997245094.SGD","LU1969619763.USD","LU1064131003.USD","LU1328615791.USD","LU2580892862.HKD","LU2148510915.USD","BK0239","LU1655091616.SGD","BK0183","BK0060","LU2488822045.USD","01276","LU1064130708.USD","BK1191","LU1997245177.USD","600276","LU2543165471.USD","LU0405327494.USD","LU0405327148.USD","BK0012","LU2580892789.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2558961744","title":"恒瑞医药：海曲泊帕乙醇胺片药品上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2558961744","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558961744?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:39","pubTimestamp":1754987994,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月12日电，恒瑞医药(600276.SH)公告称，公司收到国家药监局下发的《受理通知书》，海曲泊帕乙醇胺片的药品上市许可申请获国家药监局受理，适应症为适用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的持续性及慢性原发免疫性血小板减少症（ITP）成人及≥6岁的儿童患者。该药品Ⅲ期临床试验已达到预设的主要研究终点，且长期治疗的安全性、有效性良好。海曲泊帕乙醇胺片已获批上市两个适应症，包括慢性原发免疫性血小板减少症成人患者的治疗和重型再生障碍性贫血成人患者的治疗。截至目前，相关项目累计研发投入约4.46亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216412697429f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216412697429f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU2543165471.USD","01276"],"gpt_icon":0},{"id":"2558617190","title":"上证消费品指数下跌0.01%，前十大权重包含中国中免等","url":"https://stock-news.laohu8.com/highlight/detail?id=2558617190","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558617190?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:18","pubTimestamp":1754986735,"startTime":"0","endTime":"0","summary":"金融界8月12日消息，上证指数高开高走，上证消费品指数 下跌0.01%，报8329.93点，成交额328.24亿元。数据统计显示，上证消费品指数近一个月上涨5.09%，近三个月上涨6.19%，年至今上涨5.77%。据了解，上证投资品、消费品指数在上证全指样本的投资品、消费品主题证券中选取规模大、流动性好的50只证券作为样本，以反映沪市投资品、消费品主题证券的整体走势。从上证消费品指数持仓样本的行业来看，医药卫生占比68.88%、主要消费占比21.91%、可选消费占比9.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216223594de6f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081216223594de6f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU2328871848.SGD","02359","LU1997245177.USD","600196","BK0183","BK0085","IE0005HP3H50.USD","BK0175","BK0196","LU1997245094.SGD","BK0028","LU1146622755.USD","603369","601888","BK0187","600276","LU1064131003.USD","BK0188","600809","01880","600519","LU1820825898.SGD","BK0010","LU1328615791.USD","603259","LU1064130708.USD","BK0012","BK0132","BK0040","LU0326950275.SGD","BK0210","000036.SH","688271","LU0593848301.USD","LU1969619763.USD","688617","LU2148510915.USD"],"gpt_icon":0},{"id":"2558694618","title":"高血压概念盘中跳水，润都股份跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558694618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558694618?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:36","pubTimestamp":1754962586,"startTime":"0","endTime":"0","summary":"08月12日，高血压概念盘中跳水，截至09点36分，高血压概念整体指数下跌0.85%，报1715.180点。从个股上来看，该概念的成分股中，润都股份跌0.45%，立方制药、信立泰、向日葵跌幅居前。从资金上来看，截止发稿，高血压概念主力净流入为-1254.99万，其中恒瑞医药受到资金热捧，主力净流入823.15万；拉长时间线来看，该板块近20日主力资金净流入-23.81亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812093626a6e08be2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812093626a6e08be2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0012","LU1064130708.USD","002923","LU2148510915.USD","LU2495084118.USD","600276","LU1328615791.USD","LU1997245177.USD","BK0196","LU2580892862.HKD","LU0405327494.USD","LU0405327148.USD","LU1064131003.USD","LU2580892789.USD","BK0028","01276","LU1997245094.SGD","BK0060","BK0183","LU1997244956.HKD","BK0239","LU1255011170.USD","LU1969619763.USD","LU2328871848.SGD","LU1655091616.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2558696429","title":"国产减肥药加速突围：如何与进口药竞争？是否还有BD预期？","url":"https://stock-news.laohu8.com/highlight/detail?id=2558696429","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558696429?lang=zh_cn&edition=full","pubTime":"2025-08-12 07:44","pubTimestamp":1754955861,"startTime":"0","endTime":"0","summary":"相较于两款进口药一周注射一次，贝那鲁肽一天三次的使用频率大大影响了市场表现，而如今的玛仕度肽具备多靶点、一周一次等特点，国产创新药终于有了与两款进口减肥药竞争的特质。此前，减肥药巨头诺和诺德因司美格鲁肽销售不及预期而下调全年业绩指引，而礼来因为口服减肥药研究数据不及预期而股价大跌。未来围绕GLP-1细分赛道，行业仍有一定的BD预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812074548a482ba28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812074548a482ba28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU0140636845.USD","BK1521","LU1152091754.HKD","BK1515","LU1226288170.HKD","LU1226287792.SGD","LU1226288253.USD","01093","LU1226287875.USD","BK1191","LU0326950275.SGD","03933","IE00B031HY20.USD","IE0008369823.USD","LU1951186391.HKD","LU1152091168.USD","LU0072913022.USD","LU1960683339.HKD","LU0315179316.USD","LU1807302812.USD","LU0880133367.SGD","LU0067412154.USD","IE0008368742.USD","01276","LU0501845795.SGD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","LU1993786604.SGD","SG9999004220.SGD","LU1226287529.USD","IE00B543WZ88.USD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2558692136","title":"港股公告掘金 | 百胜中国中期净利润5.07亿美元 同比增加1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558692136","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558692136?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:00","pubTimestamp":1754924430,"startTime":"0","endTime":"0","summary":"重大事项：天岳先进(02631)8月11日-8月14日招股 拟全球发售4774.57万股H股恒瑞医药(01276)：注射用瑞康曲妥珠单抗、阿得贝利单抗注射液纳入拟突破性治疗品种公示名单首程控股(00697)投资南方万国数据中心REIT和南方润泽科技数据中心REIT博雅互动(00434)被纳入MSCI全球小型股指数成份股经营业绩：百胜中国(09987)发布中期业绩，净利润5.07亿美元 同比增加1.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00434","00268","03337","00322","YANG","YUMC","HSTECH","07226","01276","HSCEI","09987"],"gpt_icon":0},{"id":"2558566381","title":"创新药这次不一样","url":"https://stock-news.laohu8.com/highlight/detail?id=2558566381","media":"乔令投研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558566381?lang=zh_cn&edition=full","pubTime":"2025-08-11 20:28","pubTimestamp":1754915287,"startTime":"0","endTime":"0","summary":"另外今天，恒生港股通创新药指数修订生效，剔除了医药外包企业，现在指数覆盖的都是创新药企，纯度达100%，而恒生创新药ETF是目前唯一跟踪该指数的产品。按Wind数据显示，恒生港股通创新药指数目前的估值分位数不到40%，PE31倍，整体估值还处在历史中位数水平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811205002a482047f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811205002a482047f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688428","BK4139","BK4526","688235","YANG","01801","01093","01530","600276","BK4585","BK4614","06160","CXO","ONC","09969","09926","01276"],"gpt_icon":0},{"id":"2558659565","title":"每日卖空追踪 | 恒瑞医药 08月11日卖空量成交32.02万股，卖空比例为11.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558659565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558659565?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:30","pubTimestamp":1754901020,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间08月11日，涨1.17%，卖空量成交32.02万股%，较上一交易日减少80.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811171426a6df4fef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811171426a6df4fef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","BK1191","01276"],"gpt_icon":0},{"id":"2558656123","title":"恒瑞医药08月11日获主力加仓1786.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558656123","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558656123?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:15","pubTimestamp":1754900127,"startTime":"0","endTime":"0","summary":"08月11日, 恒瑞医药股价涨1.17%，报收77.60元，成交金额2.2亿元，换手率1.10%，振幅3.39%，量比0.70。恒瑞医药今日主力资金净流入1786.8万元，连续3日净流入，上一交易日主力净流入819.9万元。该股近5个交易日下跌1.77%，主力资金累计净流入3897.4万元；近20日主力资金累计净流出1.5亿元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811165149a4819fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811165149a4819fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","BK1191","LU2543165471.USD"],"gpt_icon":0},{"id":"2558374076","title":"智通AH统计|8月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2558374076","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558374076?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:15","pubTimestamp":1754900106,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止8月11日收盘，东北电气、弘业期货、安德利果汁分列AH溢价率前三位，溢价率分别为770.97%、221.01%、219.72%；宁德时代、恒瑞医药、招商银行分列AH溢价率末三位，溢价率分别为-24.16%、-5.73%、6.71%。其中安德利果汁、北京北辰实业股份、山东墨龙的偏离值位居前三，分别为34.07%、19.49%、12.60%；另外，比亚迪股份、东北电气、龙蟠科技的偏离值位居后三，分别为-170.41%、-108.95%、-46.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02338","LU0449509016.USD","LU1960683339.HKD","09696","LU1282648689.USD","06680","00300","01349","00916","01288","02727","06127","IE00BVYPNQ40.USD","02238","LU0228659784.USD","00187","02039","03968","03143","BYDDY","02218","00895","03750","01618","01772","159982","002594","00588","BK1514","06869","01276","02465","HYDD.SI","81211","00568","01033","399300","01057","02899","01211","03678","00042","LU1303224171.USD","LU0117841782.USD","01456","01812","02359","BK1205","BK1110"],"gpt_icon":1},{"id":"2558313653","title":"创新药行情扩散，医药子行业轮动开启！","url":"https://stock-news.laohu8.com/highlight/detail?id=2558313653","media":"华夏ETF","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558313653?lang=zh_cn&edition=full","pubTime":"2025-08-11 16:01","pubTimestamp":1754899270,"startTime":"0","endTime":"0","summary":"事件及点评8月6日，包括乐普生物、百济神州等头部医药企业发布2025年第二季度财务数据公告，半年度盈利转正。目前已进入中报披露高峰期，伴随国产创新药大额BD交易持续，利好政策逐步落实，医药底部子行业均呈现反转特征。7月医药生物的各二级行业中，所有子行业均同步上涨，医疗服务、化学制药、生物制品、医疗器械，轮动开启。在当前创新药持续估值修复带动下，中报数据验证有望催化估值修复行情向多环节扩散。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811160327a6df2cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811160327a6df2cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","688235","01093","ONC","02157","BK4526","600276","BK4139","BK4585","01276"],"gpt_icon":0},{"id":"2558663297","title":"恒瑞 1 类新药新适应症报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2558663297","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558663297?lang=zh_cn&edition=full","pubTime":"2025-08-11 15:29","pubTimestamp":1754897389,"startTime":"0","endTime":"0","summary":"8 月 11 日，CDE 官网显示，恒瑞海曲泊帕乙醇胺片新适应症上市申请获受理。2022 年 6 月，海曲泊帕乙醇胺片用于恶性肿瘤化疗所致血小板减少症适应症获得美国 FDA 授予的孤儿药资格认定。2024 年 6 月，恒瑞在 2024 ESMO 大会上公布了海曲泊帕乙醇胺片治疗恶性肿瘤化疗所致血小板减少症的 III 期临床数据。结果显示，海曲泊帕乙醇胺片组的治疗应答者比例显著高于安慰剂组。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811153934a6df20c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811153934a6df20c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","LU2495084118.USD","LU2580892789.USD","BK0196","LU1997245177.USD","LU1655091616.SGD","01276","LU1997244956.HKD","LU1064131003.USD","BK0183","BK0239","BK0060","600276","LU2148510915.USD","LU0405327494.USD","LU2580892862.HKD","LU1997245094.SGD","LU2488822045.USD","BK0012","LU2328871848.SGD","LU1969619763.USD","LU1064130708.USD","BK0028","LU1255011170.USD","LU0405327148.USD","LU1328615791.USD"],"gpt_icon":0},{"id":"2558631925","title":"陕西嘉泽恒瑞贸易有限责任公司成为中铁二十二局集团电气化工程有限公司物资采购项目第一候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2558631925","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558631925?lang=zh_cn&edition=full","pubTime":"2025-08-11 14:06","pubTimestamp":1754892362,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年8月11日，中铁二十二局集团电气化工程有限公司发布襄渝线视频监控补强工程项目部自购物资（监控设备箱）询比价结果公示。根据公告内容，陕西嘉泽恒瑞贸易有限责任公司被列为JKSBX-01包件号的第一候选人。该项目采购编号为YC-CGJH-2508-0076，采购人为中铁二十二局集团电气化工程有限公司襄渝线视频监控补强工程项目部，公示时间从2025年8月11日至2025年8月14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081114084394dc2348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081114084394dc2348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","LU1997245094.SGD","LU2580892862.HKD","LU1969619763.USD","LU2488822045.USD","BK0188","LU0405327148.USD","BK0239","LU1064130708.USD","LU2328871848.SGD","LU2148510915.USD","LU1997244956.HKD","LU2495084118.USD","LU1997245177.USD","BK0183","LU1655091616.SGD","LU1328615791.USD","LU2580892789.USD","BK0060","BK0028","LU1255011170.USD","LU0405327494.USD","BK0196","LU1064131003.USD","BK0012","01276"],"gpt_icon":0},{"id":"2558166639","title":"花旗.张凌：过去半年生物科技融资，出现东升西降，香港资本市场突发猛进","url":"https://stock-news.laohu8.com/highlight/detail?id=2558166639","media":"瑞恩资本Ryanbe...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558166639?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:18","pubTimestamp":1754889536,"startTime":"0","endTime":"0","summary":"但过去6个月出现东升西降趋势，香港资本市场突发猛进，美国生物科技资本市场反而相对安静。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811132501a4814634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811132501a4814634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1328615791.USD","600276","BK0188","BK0028","BK0060","01276","BK0012","603259","LU1997245177.USD","BK0239","LU0405327494.USD","LU2580892862.HKD","LU1064130708.USD","LU1255011170.USD","LU1064131003.USD","LU2148510915.USD","LU1969619763.USD","LU1997244956.HKD","LU1655091616.SGD","LU2580892789.USD","LU2328871848.SGD","02359","LU0405327148.USD","BK0183","LU1997245094.SGD","LU2495084118.USD","BK0196","LU2488822045.USD","159837"],"gpt_icon":0},{"id":"2558201638","title":"市值重返4000亿，恒瑞医药凭什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2558201638","media":"砺石商业评论","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558201638?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:43","pubTimestamp":1754880205,"startTime":"0","endTime":"0","summary":"根据双方协议，恒瑞医药将获得来自GSK的5亿美元首付款。消息公布后，恒瑞医药的A股股价直奔涨停，公司总市值一举突破4000亿元大关，创下近4年来新高。恒瑞医药H股股价更是暴涨超24.5%，总市值突破5600亿港元，总市值单日涨幅超过1100亿港元。鉴于恩塞芬汀良好的市场前景，2025年7月9日，默沙东宣布以100亿美元收购Verona Pharma，进而将恩司芬群招入麾下。2022年年中，恒瑞医药市值一度跌至2000亿元，总市值蒸发超过4000亿元。","market":"sh","thumbnail":"https://static.tigerbbs.com/e459105908d93cf4290a35218cd89be5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e459105908d93cf4290a35218cd89be5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/cUFYYIjD2OePW218b_8UAw","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"市值重返4000亿，恒瑞医药凭什么？","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1571105524917","symbols":["600276","01276"],"gpt_icon":0},{"id":"1102457711","title":"AH溢价创2020年以来新低！中金：长期收敛但无法抹平，个股倒挂但无法推广","url":"https://stock-news.laohu8.com/highlight/detail?id=1102457711","media":"中金点睛","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102457711?lang=zh_cn&edition=full","pubTime":"2025-08-11 08:44","pubTimestamp":1754873063,"startTime":"0","endTime":"0","summary":"近期，AH溢价从4月初高点144%快速回落至7月底的123%，创2020年以来新低，当前仍处于125%的低位；宁德时代、恒瑞医药等A to H上市后表现优异，当前分别交易31%和15%的倒挂。AH溢价指数发布首日收于133%，随后受金融危机冲击，A股跌幅远超港股，一度导致AH溢价跌破100%。图表：红利和新经济板块AH溢价较低注：数据截至2025年8月8日  资料来源：Wind，中金公司研究部 市值层面，小盘股AH溢价高于大盘股。","market":"sh","thumbnail":"https://community-static.tradeup.com/news/0f3b3659e41cdd8827db664785762e39","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/0f3b3659e41cdd8827db664785762e39"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/bdgSpijv1ErlzbfkpYKVbA","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zjdj","symbols":["300750","01276","600276","03750"],"gpt_icon":1},{"id":"2558894576","title":"当AH股溢价率小于20%，银行股还香吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2558894576","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558894576?lang=zh_cn&edition=full","pubTime":"2025-08-10 20:46","pubTimestamp":1754829960,"startTime":"0","endTime":"0","summary":"AH股溢价率大幅收敛今年以来，南向资金净买入规模已经超过去年全年。因此，当AH股溢价率大幅收敛，甚至低于20%，为了分红而去购买银行H股的投资者就不得不考虑获取价差的成本。截至最新交易日8月8日，上市银行AH股溢价率小于20%的个股，包括招商银行（倒挂）、邮储银行、民生银行、光大银行、重庆农商行等。而中金公司是目前AH股价差最大的券商股之一，A股比H股要贵一倍，中信建投更是如此，AH股溢价率超过200%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081020552294daf61d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081020552294daf61d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","CMAKY","03143","LU0314109678.HKD","CIIHY","03968","BK1560","LU0196878994.USD","600036","600276","BK1231","03750","601818","601658","LU1813983027.USD","01988","01276","LU1328277881.USD","HSCEI","LU2039709279.SGD","01658","CIHKY","600016","LU0348805143.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.hrs.com.cn","stockEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":0.0556},{"period":"3month","weight":0.7889},{"period":"ytd","weight":0.7889}],"compareEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.0921},{"period":"6month","weight":0.1323},{"period":"1year","weight":0.4914},{"period":"ytd","weight":0.2769}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏恒瑞医药股份有限公司是一家主要从事药品的研发、生产和销售的中国公司。该公司专注于肿瘤领域，覆盖激酶抑制剂、抗体偶联药物（ADC）、肿瘤免疫、激素受体调控、脱氧核糖核酸（DNA）修复及表观遗传、支持治疗等研究领域。该公司的产品包括抗肿瘤、镇痛麻醉和造影剂，应用于自身免疫疾病、代谢性疾病、心血管疾病、感染疾病、呼吸系统疾病、血液疾病、疼痛管理、神经系统疾病、眼科、肾病等领域。该公司主要在国内外市场开展其业务。","exchange":"SEHK","name":"恒瑞医药","nameEN":"HENGRUI PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"恒瑞医药,01276,恒瑞医药股票,恒瑞医药股票老虎,恒瑞医药股票老虎国际,恒瑞医药行情,恒瑞医药股票行情,恒瑞医药股价,恒瑞医药股市,恒瑞医药股票价格,恒瑞医药股票交易,恒瑞医药股票购买,恒瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}